Tvardi Therapeutics, Inc. ( TVRD) - Stock Earnings
TVRD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 4.2 million USD | — USD |
| 2025Q3 | -5.5 million USD | — USD |
| 2025Q4 | -7.3 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
TVRD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.5 million USD | 21.0 million USD |
| 2024 | -70.9 million USD | 7.1 million USD |
| 2025 | -18.2 million USD | — USD |
| 2026 Est. | — | — |
TVRD
Price: $2.63
52 week price:
Earnings Per Share: -3.26 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 27.1 million